PRESS RELEASE published on 10/06/2026 at 06:30, 1 month 3 days ago Formycon Optimizes Biosimilar Development with AI-Powered Technologies: Digital Solutions Enhance Development Efficiency as Part of the FYB4GROWTH Strategy Formycon optimizes biosimilar development with AI-powered technologies to enhance efficiency and competitiveness as part of the FYB4GROWTH strategy Digital Solutions Formycon Biosimilar Development FYB4Growth AI-powered Technologies
BRIEF published on 09/22/2026 at 06:35, 1 month 17 days ago Formycon Publishes Breakthrough in Biosimilar Development for FYB206 FYB206 Biosimilar Development Regulatory Science Pharmacokinetic Focus BioDrugs
BRIEF published on 09/22/2026 at 06:35, 1 month 17 days ago Formycon annonce une avancée majeure dans le développement d'un biosimilaire pour le FYB206 FYB206 Biomédicaments Développement Des Biosimilaires Focus Pharmacocinétique Sciences Réglementaires
PRESS RELEASE published on 09/22/2026 at 06:30, 1 month 17 days ago Formycon sets Benchmark in Biosimilar Development: Scientific Foundation of the innovative Development Program for FYB206 published in the Journal BioDrugs Formycon sets a benchmark in biosimilar development with the publication of the scientific foundation of the innovative development program for FYB206 in the Journal BioDrugs Formycon FYB206 Biosimilar Development Scientific Publication BioDrugs
BRIEF published on 08/12/2026 at 06:35, 2 months 28 days ago Formycon annonce une croissance financière significative au premier semestre 2026 Formycon AG Marché Des Biosimilaires Résultats Financiers 2026 FYB206 Pembrolizumab Stratégie De Croissance FYB4
BRIEF published on 08/12/2026 at 06:35, 2 months 28 days ago Formycon Reports Significant Financial Growth in H1 2026 Formycon AG Biosimilar Market Financial Results 2026 FYB4Growth Strategy FYB206 Pembrolizumab
PRESS RELEASE published on 08/12/2026 at 06:30, 2 months 28 days ago Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year. Successful clinical development enhances Formycon's position in biosimilars Financial Results Clinical Development Biosimilars Formycon Operational Achievements
BRIEF published on 08/05/2026 at 06:35, 3 months 4 days ago Formycon Schedules Conference Call and Participation in Investor Conferences Financial Results Conference Call Investor Conferences Formycon AG Biosimilars
BRIEF published on 08/05/2026 at 06:35, 3 months 4 days ago Formycon programme une conférence téléphonique et sa participation à des conférences d'investisseurs. Résultats Financiers Formycon AG Conférence Téléphonique Conférences D'investisseurs Biosimilaires
PRESS RELEASE published on 08/05/2026 at 06:30, 3 months 4 days ago Formycon invites to conference call on 2026 half-year results and announces participation in international investor conferences Formycon AG to discuss 2026 half-year results in conference call and attend investor conferences. Learn more at www.formycon.com Financial Results Conference Call Investor Conferences Formycon AG Biosimilars
Published on 11/06/2026 at 22:15, 2 days 13 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 23 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 23 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 23 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 11:05, 1 hour ago Velvet, mirrors and rooms upstairs: inside Lisbon's Pensão Amor
Published on 11/09/2026 at 11:00, 1 hour 5 minutes ago LINXAI Robotics Claims Gold and Two Bronzes at First CMG World Robot Mount Tai Competition
Published on 11/09/2026 at 10:55, 1 hour 10 minutes ago Huawei Recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Infrastructure Platform Consumption Services
Published on 11/09/2026 at 10:32, 1 hour 33 minutes ago Disclosure of shares outstanding and voting rights - 09.11.2026
Published on 11/09/2026 at 10:32, 1 hour 33 minutes ago Déclaration nombre d'actions et droits de vote - 09.11.2026
Published on 11/09/2026 at 07:00, 5 hours 5 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 5 hours 5 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 5 hours 5 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine